Cargando…

Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer

The trimeric envelope (Env) spike is the focus of vaccine design efforts aimed at generating broadly neutralizing antibodies (bNAbs) to protect against HIV-1 infection. Three recent developments have facilitated a thorough investigation of the antigenic structure of the Env trimer: 1) the isolation...

Descripción completa

Detalles Bibliográficos
Autores principales: Derking, Ronald, Ozorowski, Gabriel, Sliepen, Kwinten, Yasmeen, Anila, Cupo, Albert, Torres, Jonathan L., Julien, Jean-Philippe, Lee, Jeong Hyun, van Montfort, Thijs, de Taeye, Steven W., Connors, Mark, Burton, Dennis R., Wilson, Ian A., Klasse, Per-Johan, Ward, Andrew B., Moore, John P., Sanders, Rogier W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373910/
https://www.ncbi.nlm.nih.gov/pubmed/25807248
http://dx.doi.org/10.1371/journal.ppat.1004767
_version_ 1782363409928421376
author Derking, Ronald
Ozorowski, Gabriel
Sliepen, Kwinten
Yasmeen, Anila
Cupo, Albert
Torres, Jonathan L.
Julien, Jean-Philippe
Lee, Jeong Hyun
van Montfort, Thijs
de Taeye, Steven W.
Connors, Mark
Burton, Dennis R.
Wilson, Ian A.
Klasse, Per-Johan
Ward, Andrew B.
Moore, John P.
Sanders, Rogier W.
author_facet Derking, Ronald
Ozorowski, Gabriel
Sliepen, Kwinten
Yasmeen, Anila
Cupo, Albert
Torres, Jonathan L.
Julien, Jean-Philippe
Lee, Jeong Hyun
van Montfort, Thijs
de Taeye, Steven W.
Connors, Mark
Burton, Dennis R.
Wilson, Ian A.
Klasse, Per-Johan
Ward, Andrew B.
Moore, John P.
Sanders, Rogier W.
author_sort Derking, Ronald
collection PubMed
description The trimeric envelope (Env) spike is the focus of vaccine design efforts aimed at generating broadly neutralizing antibodies (bNAbs) to protect against HIV-1 infection. Three recent developments have facilitated a thorough investigation of the antigenic structure of the Env trimer: 1) the isolation of many bNAbs against multiple different epitopes; 2) the generation of a soluble trimer mimic, BG505 SOSIP.664 gp140, that expresses most bNAb epitopes; 3) facile binding assays involving the oriented immobilization of tagged trimers. Using these tools, we generated an antigenic map of the trimer by antibody cross-competition. Our analysis delineates three well-defined epitope clusters (CD4 binding site, quaternary V1V2 and Asn332-centered oligomannose patch) and new epitopes at the gp120-gp41 interface. It also identifies the relationships among these clusters. In addition to epitope overlap, we defined three more ways in which antibodies can cross-compete: steric competition from binding to proximal but non-overlapping epitopes (e.g., PGT151 inhibition of 8ANC195 binding); allosteric inhibition (e.g., PGT145 inhibition of 1NC9, 8ANC195, PGT151 and CD4 binding); and competition by reorientation of glycans (e.g., PGT135 inhibition of CD4bs bNAbs, and CD4bs bNAb inhibition of 8ANC195). We further demonstrate that bNAb binding can be complex, often affecting several other areas of the trimer surface beyond the epitope. This extensive analysis of the antigenic structure and the epitope interrelationships of the Env trimer should aid in design of both bNAb-based therapies and vaccines intended to induce bNAbs.
format Online
Article
Text
id pubmed-4373910
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43739102015-03-27 Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer Derking, Ronald Ozorowski, Gabriel Sliepen, Kwinten Yasmeen, Anila Cupo, Albert Torres, Jonathan L. Julien, Jean-Philippe Lee, Jeong Hyun van Montfort, Thijs de Taeye, Steven W. Connors, Mark Burton, Dennis R. Wilson, Ian A. Klasse, Per-Johan Ward, Andrew B. Moore, John P. Sanders, Rogier W. PLoS Pathog Research Article The trimeric envelope (Env) spike is the focus of vaccine design efforts aimed at generating broadly neutralizing antibodies (bNAbs) to protect against HIV-1 infection. Three recent developments have facilitated a thorough investigation of the antigenic structure of the Env trimer: 1) the isolation of many bNAbs against multiple different epitopes; 2) the generation of a soluble trimer mimic, BG505 SOSIP.664 gp140, that expresses most bNAb epitopes; 3) facile binding assays involving the oriented immobilization of tagged trimers. Using these tools, we generated an antigenic map of the trimer by antibody cross-competition. Our analysis delineates three well-defined epitope clusters (CD4 binding site, quaternary V1V2 and Asn332-centered oligomannose patch) and new epitopes at the gp120-gp41 interface. It also identifies the relationships among these clusters. In addition to epitope overlap, we defined three more ways in which antibodies can cross-compete: steric competition from binding to proximal but non-overlapping epitopes (e.g., PGT151 inhibition of 8ANC195 binding); allosteric inhibition (e.g., PGT145 inhibition of 1NC9, 8ANC195, PGT151 and CD4 binding); and competition by reorientation of glycans (e.g., PGT135 inhibition of CD4bs bNAbs, and CD4bs bNAb inhibition of 8ANC195). We further demonstrate that bNAb binding can be complex, often affecting several other areas of the trimer surface beyond the epitope. This extensive analysis of the antigenic structure and the epitope interrelationships of the Env trimer should aid in design of both bNAb-based therapies and vaccines intended to induce bNAbs. Public Library of Science 2015-03-25 /pmc/articles/PMC4373910/ /pubmed/25807248 http://dx.doi.org/10.1371/journal.ppat.1004767 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
spellingShingle Research Article
Derking, Ronald
Ozorowski, Gabriel
Sliepen, Kwinten
Yasmeen, Anila
Cupo, Albert
Torres, Jonathan L.
Julien, Jean-Philippe
Lee, Jeong Hyun
van Montfort, Thijs
de Taeye, Steven W.
Connors, Mark
Burton, Dennis R.
Wilson, Ian A.
Klasse, Per-Johan
Ward, Andrew B.
Moore, John P.
Sanders, Rogier W.
Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer
title Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer
title_full Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer
title_fullStr Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer
title_full_unstemmed Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer
title_short Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer
title_sort comprehensive antigenic map of a cleaved soluble hiv-1 envelope trimer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373910/
https://www.ncbi.nlm.nih.gov/pubmed/25807248
http://dx.doi.org/10.1371/journal.ppat.1004767
work_keys_str_mv AT derkingronald comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer
AT ozorowskigabriel comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer
AT sliepenkwinten comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer
AT yasmeenanila comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer
AT cupoalbert comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer
AT torresjonathanl comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer
AT julienjeanphilippe comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer
AT leejeonghyun comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer
AT vanmontfortthijs comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer
AT detaeyestevenw comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer
AT connorsmark comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer
AT burtondennisr comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer
AT wilsoniana comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer
AT klasseperjohan comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer
AT wardandrewb comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer
AT moorejohnp comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer
AT sandersrogierw comprehensiveantigenicmapofacleavedsolublehiv1envelopetrimer